Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02588170
Brief Title: Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

First Submitted : October 26, 2015
First Submitted that Met QC Criteria : October 26, 2015
First Posted : October 27, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 18, 2019
Last Update Posted : November 19, 2019